1. Spiderwort, a startup developing cellulose-based tissue scaffolding to treat acute spinal cord injuries, has secured $13.2 million through a series A financing round
2. NovaBone, a biologic medtech company focused on orthopedic and dental products, hired Brian Carlisle as CEO
3. AlloSource’s president and CEO, Tom Cycyota, announced plans to retire after leading the biologics company for 22 years
4. Orthofix and CGBio partnered for the development and commercialization of Novosis, a bone growth material and regenerative products
5. Randal “Randy” Mills, PhD, co-founder of Aziyo Biologics, assumed the role of president and CEO of the company
6. Richard Caruso, PhD, founder, former CEO and former chair of Integra lifeSciences, has died
7. Ortho Regenerative Technologies changed its name to ChitogenX.
8. Ventris Medical’s Amplify synthetic bone graft putty earned FDA 510(k) clearance.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
